ESSA Pharma Inc.

NASDAQ:EPIX

5.74 (USD) • At close October 22, 2024
Bedrijfsnaam ESSA Pharma Inc.
Symbool EPIX
Munteenheid USD
Prijs 5.74
Beurswaarde 254,677,819
Dividendpercentage 0%
52-weken bereik 3.8 - 11.67
Industrie Biotechnology
Sector Healthcare
CEO Dr. David Ross Parkinson M.D.
Website https://www.essapharma.com

An error occurred while fetching data.

Over ESSA Pharma Inc.

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements

Vergelijkbare Aandelen

AC Immune SA logo

AC Immune SA

ACIU

3.11 USD

Precigen, Inc. logo

Precigen, Inc.

PGEN

0.937 USD

Alpine Immune Sciences, Inc. logo

Alpine Immune Sciences, Inc.

ALPN

64.97 USD

Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc.

TNYA

1.91 USD

AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc.

ANTX

1.08 USD

Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

DYN

33.39 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)